Proteome Sciences plc (LON:PRM – Get Free Report) shares fell 1.4% during trading on Tuesday. The company traded as low as GBX 1.04 and last traded at GBX 1.38. Approximately 499,557 shares were traded during trading, an increase of 45% from the average daily volume of 345,071 shares. The stock had previously closed at GBX 1.40.
Proteome Sciences Price Performance
The stock has a 50-day simple moving average of GBX 1.43 and a 200 day simple moving average of GBX 1.61. The company has a debt-to-equity ratio of -161.07, a quick ratio of 0.37 and a current ratio of 0.12. The company has a market cap of £4.84 million, a P/E ratio of -1.92 and a beta of 0.16.
Proteome Sciences (LON:PRM – Get Free Report) last announced its quarterly earnings results on Wednesday, September 16th. The company reported GBX (0.41) EPS for the quarter. Proteome Sciences had a positive return on equity of 23.85% and a negative net margin of 61.46%.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
